MacroGenics to receive $122.5 million upfront payment from Bora upon closing•Transaction includes transfer of manufacturing site, CDMO ...

Seasoned leader joins executive team to support global expansion and long-term value creationNEWTOWN, Pa., May 12, 2026 /PRNewswire/ -- Catalyx, a global leader in AI-powered machine vision ...

MacroGenics to receive $122.5 million upfront payment from Bora upon closing•Transaction includes transfer of manufacturing site, CDMO operations and associated personnel to Bora ROCKVILLE, MD, May ...

The DNA synthesis market is witnessing strong adoption across pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and synthetic ...

Cell-Free DNA assembly company, Ribbon Bio, has today announced two major strategic advances designed to remove long‑standing constraints in DNA production and broaden access to high‑quality synthetic ...

Advancing small molecules from R&D to GMP requires coordinated strategies to support phase I clinical manufacturing.

The key market opportunities include enhanced GMP implementation for improved efficiency and compliance in the pharmaceutical industry, leveraging technological advancements, and adapting to rigorous ...

Bis-(3′-5′)-cyclic dimeric guanosine monophosphate (c-di-GMP) is a ubiquitous bacterial second-messenger molecule that is involved in the molecular decision between planktonic motile and sedentary ...

Allied Market Research has released a report titled, 'Life Science IT Market Size, Share by Solution (Drug Discovery ...

Continuous monitoring ensures contamination control and GMP compliance in pharmaceutical cleanrooms, supporting sterility and ...

A WA biotech duo, ProGenis and Syngenis Laboratories, is developing RNA-based therapies at the next frontier in diabetes ...

Conversations with manufacturing CEOs are rooted in strategy, risk and performance, highlighting the evolving expectations ...